196 related articles for article (PubMed ID: 33545956)
1. Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial.
Yang H; Liu X; Peng W; Chen R; Chen Y
Medicine (Baltimore); 2021 Jan; 100(3):e23887. PubMed ID: 33545956
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
[TBL] [Abstract][Full Text] [Related]
3. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
Leighton MP; Lam C; Mehta S; Spiller RC
Trials; 2013 Jan; 14():10. PubMed ID: 23302220
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
Wang XX; Luo RJ; She B; Chen Y; Guo J
Trials; 2014 Jul; 15():273. PubMed ID: 25002196
[TBL] [Abstract][Full Text] [Related]
8. [Treating irritable bowel syndrome with diarrhea patients by yigan fupi decoction: a randomized controlled trial].
Chen MX; Chen JX; Xia L; Fu R; Lu Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):656-60. PubMed ID: 25046944
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
10. Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.
Tan X; Zhao XJ; Li JX; Xie CE; Pei WJ; Shi L; Kou FS; Yuan YL; Xue XX
Medicine (Baltimore); 2020 Dec; 99(52):e23868. PubMed ID: 33350782
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
[TBL] [Abstract][Full Text] [Related]
12. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
Ji L; Zhao X; Zhang Y; Zhao P; Gong R; Li F; Huang H
Medicine (Baltimore); 2022 Mar; 101(9):e28895. PubMed ID: 35244043
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
Zheng Y; Ching J; Cheng CW; Lam WC; Chan KL; Zhang X; Lam PY; Wu XY; Zhong LLD; Cao PH; Lo CW; Cheong PK; Lin Z; Koh M; Wu J; Bian ZX
Chin Med; 2021 Nov; 16(1):117. PubMed ID: 34774080
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
16. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial.
Sun JW; Sun ML; Li D; Zhao J; Shi SH; Li HX; Liu HM; Gao JX; Hu Y; Zheng H; Wang X; Xue RD; Feng X; Yu SG; Li ZG
Trials; 2021 Oct; 22(1):719. PubMed ID: 34666815
[TBL] [Abstract][Full Text] [Related]
19. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
20. The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
Guo X; Xuan M; Zheng H; Qin S; Wu H; Huang S; Wen Z
Trials; 2021 Jul; 22(1):491. PubMed ID: 34311755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
